Insider Activity Report: T-Mobile (TMUS)
Andre Almeida, a director at T-Mobile (TMUS), recently bought 3,808 shares. The buy came to a total cost of $897,528, and is an initial stake for the director.
This is also the first insider buy over the past two years. Company insiders have been sellers of shares, including the sale of large stake from major holder Deutsche Telekom. Major executives including the CEO and CFO have also been scaling out of their position recently.
Overall, T-Mobile insiders still own 59.2% of ...
Read More About This
Read More About This
Unusual Options Activity: CleanSpark (CLSK)
Bitcoin mining operator CleanSpark (CLSK) is up 11% over the past year, far underperforming the return of bitcoin itself, which more than doubled. One trader sees CLSK staging a rally in the coming weeks.
That’s based on the January 31 $17.50 calls. With 23 days until expiration, 5,359 contracts traded compared to a prior open interest of 110, for a 49-fold rise in volume on the trade. The buyer of the calls paid $0.17 to make the bullish bet.
CleanSpark shares recently ...
Read More About This
Read More About This
Wealthy Household Spending Remains High In This Space
Consumer tastes are shifting, and lower-income consumers may have to cut back on big spending this year amid a rise in credit card delinquencies. For higher-income homes, some areas won’t see much of a cutback in spending at all.
The most likely place to hold up is with fine dining, even fine at home dining. Upper-income homes continue to spend well on high-end menu items. That bodes well for premium ingredient providers.
One such player is Chef’s Warehouse (CHEF), which distributes Read More About This
Insider Activity Report: Verisign (VRSN)
Berkshire Hathaway (BRK-B), a major holder of Verisign (VRSN), recently added to that stake with three buys over the past month. The buys came to a total cost of just over $89 million, increasing Berkshire’s stake by 4%.
This cluster of buys marks the first insider buying at Verisign over the past two years. Going further back, company directors and officers have been sellers of shares on a steady basis.
Overall, Verisign insiders own 14.4% of shares.
The internet infrastructure company is ...
Read More About This
Read More About This
Unusual Options Activity: U.S. Steel (X)
Steel producer U.S. Steel (X) fell 5% last week after President Biden refused to allow the company’s sale. Over the past year, shares are now down over 33%. One trader sees a short-term rebound following the selloff.
That’s based on the April $40 calls. With 100 days until expiration, 21,059 contracts traded compared to a prior open interest of 333, for a 63-fold rise in volume on the trade. The buyer of the calls paid $1.28 to make the bullish bet.
U.S ...
Read More About This
Read More About This
This Underperforming Sector Could Hold Up Well in 2025
Behind the overall stock market numbers, many individual sectors move in different ways at different times. Some sectors tend to be runaway winners some years, but are highly cyclical and trend lower in others.
Other sectors tend to be steadier, and could hold up well if the overall market has a poor year. Looking to 2025 and the market’s early struggles so far, investors may want to look for safety in an underperforming space.
That space is the restaurant industry. While rising ...
Read More About This
Read More About This
Insider Activity Report: CME Group (CME)
William Shepard, a director at CME Group (CME), recently bought 276 shares. The buy came to a total cost of $64,282, and increased his position by less than 1%.
Shepard is a quarterly buyer of shares, and picked up a similar dollar amount of shares in September, June, March, and January of 2024. Otherwise, several company insiders, including the company CIO, were slight sellers of shares over the past three months.
Overall, CME Group insiders own 0.5% of shares.
The stock exchange ...
Read More About This
Read More About This
Unusual Options Activity: AstraZeneca (AZN)
Drug manufacturer AstraZeneca (AZN) is down 30% from its peak last summer, and shares are now down on a 12-month basis. One trader sees a potential bounce higher in the weeks ahead.
That’s based on the March 21 $72.50 calls. With 73 days until expiration, 5,037 contracts traded compared to a prior open interest of 116, for a 43-fold rise in volume on the trade. The buyer of the calls paid $0.92 to make the bullish bet.
AstraZeneca shares recently traded for ...
Read More About This
Read More About This